Submicroscopic deletion of FGFR1 gene is recurrently detected in myeloid and lymphoid neoplasms associated with ZMYM2-FGFR1 rearrangements: A case study

Acta Haematologica

Volumn 127, Issue 2, 2012, Pages 119-123

  Yang, John Jeongseok ^a   Park, Tae Sung ^a   Choi, Jong Rak ^b   Park, Seo Jin ^b   Cho, Sun Young ^a   Jun, Kyung Ran ^c   Kim, Hye Ran ^c   Lee, Jeong Nyeo ^c   Oh, Seung Hwan ^c   Lee, Sanggyu ^d   Kim, Bomi ^c   Marschalek, Rolf ^e   Meyer, Claus ^e  

^a Kyung Hee University Hospital   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Kyungpook National University   (South Korea)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; ETOPOSIDE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; IFOSFAMIDE; KI 67 ANTIGEN; METHOTREXATE; PREDNISONE; PROTEIN TYROSINE KINASE;

ADAM32 GENE; ADAM3A GENE; ADAM5P GENE; ADAM9 GENE; ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BONE MARROW TUMOR; C8ORF86 GENE; CASE REPORT; CERVICAL LYMPH NODE; CHROMOSOME 8P; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 8; COPY NUMBER VARIATION; EOSINOPHILIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; GRANULOCYTOSIS; HTRA4 GENE; HUMAN; INTERPHASE; LYMPHATIC SYSTEM TUMOR; LYMPHOID CELL; MALE; METAPHASE; MICROARRAY ANALYSIS; MULTIPLE CYCLE TREATMENT; PLEKHA2 GENE; PRIORITY JOURNAL; RNF5P1 GENE; SUBMICROSCOPIC DELETION; T CELL LYMPHOMA; TACC1 GENE; TM2D2 GENE;

BASE SEQUENCE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 8; DNA-BINDING PROTEINS; FATAL OUTCOME; GENE DELETION; GENE REARRANGEMENT; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYELOPROLIFERATIVE DISORDERS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; TRANSCRIPTION FACTORS;

EID: 84862779465     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000334707     Document Type: Article

References (23)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC, 2008.
2. Macdonald D, Reiter A, Cross NC: The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol 2002; 107: 101-107. (Pubitemid 34264174)
3. Jackson CC, Medeiros LJ, Miranda RN: 8p11 myeloproliferative syndrome: a review. Hum Pathol 2010; 41: 461-476.
4. Huret JL: FGFR1 (fibroblast growth factor receptor 1). 2008. http://AtlasGeneticsOncology.org/Genes/FGFR1113.html.
5. Popovici C, Adélaïde J, Ollendorff V, Chaffanet M, Guasch G, Jacrot M, Leroux D, Birnbaum D, Pébusque MJ: Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8; 13). Proc Natl Acad Sci USA 1998; 95: 5712-5717. (Pubitemid 28224161)
6. Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald DH, Aguiar RC, Gonçalves C, Hernandez JM, Jennings BA, Goldman JM, Cross NC: Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8; 13)(p11;q12) myeloproliferative syndrome. Blood 1998; 92: 1735-1742. (Pubitemid 28406879)
7. Chen J, Deangelo DJ, Kutok JL, Williams IR, Lee BH, Wadleigh M, Duclos N, Cohen S, Adelsperger J, Okabe R, Coburn A, Galinsky I, Huntly B, Cohen PS, Meyer T, Fabbro D, Roesel J, Banerji L, Griffin JD, Xiao S, Fletcher JA, Stone RM, Gilliland DG: PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci USA 2004; 101: 14479-14484. (Pubitemid 39346774)
8. Meyer C, Schneider B, Reichel M, Angermueller S, Strehl S, Schnittger S, Schoch C, Jansen MW, van Dongen JJ, Pieters R, Haas OA, Dingermann T, Klingebiel T, Marschalek R: Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc Natl Acad Sci USA 2005; 102: 449-454. (Pubitemid 40116787)
9. Etienne A, Gelsi-Boyer V, Carbuccia N, Adelaide J, Barba G, La Starza R, Murati A, Eclache V, Birg F, Birnbaum D, Mozziconacci MJ, Mecucci C, Chaffanet M: Combined translocation with ZNF-198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder. Cancer Genet Cytogenet 2007; 173: 154-158. (Pubitemid 46281346)
10. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B, Green AR: Large deletions at the t(9; 22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 2000; 95: 738-743.
11. Jeong S, Lee DS, See CJ, Ko EK, Park S, Cho HI: The incidence of ABL deletion on derivative 9 chromosome in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with progression to blast crisis. Korean J Lab Med 2000; 20: 521-526.
12. Lee YK, Kim YR, Lee DS, She CJ, Yoon SS, Park SY, Kim BK, Cho HI: Clinical implication of the deletion status of ABL-BCR on derivative chromosome 9 in chronic myelogenous leukemia. Korean J Lab Med 2002; 22: 373-381.
13. Kim MJ, Yoon HS, Lim G, Kim SY, Lee HJ, Suh JT, Lee J, Lee WI, Park TS: ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review. Cancer Genet Cytogenet 2010; 196: 184-188.
14. Huh J, Jung CW, Kim JW, Kim HJ, Kim SH, Shin MG, Kim YK, Joon Kim H, Suh JS, Moon JH, Sohn SK, Nam GH, Lee JE, Kim DH: Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia. Ann Hematol 2011; 90: 1255-1264.
15. Yang JJ, Oh SH, Cho SY, Suh JT, Lee HJ, Lee WI, Lee J, Baek SK, Yoon HJ, Cho EH, Park TS: Submicroscopic deletion of RUNX1 gene confirmed by high resolution microarray in acute myeloid leukemia with RUNX1/RUNX1T1 rearrangement. Acta Haematol 2011; 127: 43-46.
16. Meyer C, Kowarz E, Hofmann J, Renneville A, Zuna J, Trka J, Ben Abdelali R, Macintyre E, De Braekeleer E, De Braekeleer M, Delabesse E, de Oliveira MP, Cave H, Clappier E, van Dongen JJ, Balgobind BV, van den Heuvel-Eibrink MM, Beverloo HB, Panzer-Grumayer R, Teigler-Schlegel A, Harbott J, Kjeldsen E, Schnittger S, Koehl U, Gruhn B, Heidenreich O, Chan LC, Yip SF, Krzywinski M, Eckert C, Moricke A, Schrappe M, Alonso CN, Schafer BW, Krauter J, Lee DA, Zur Stadt U, Te Kronnie G, Sutton R, Izraeli S, Trakhtenbrot L, Lo Nigro L, Tsaur G, Fechina L, Szczepanski T, Strehl S, Ilencikova D, Molkentin M, Burmeister T, Dingermann T, Klingebiel T, Marschalek R: New insights to the MLL recombinome of acute leukemias. Leukemia 2009; 23: 1490-1499.
17. Lee SG, Park TS, Oh SH, Park JC, Yang YJ, Marschalek R, Meyer C, Cho EH, Shin SY: De novo acute myeloid leukemia associated with t(11; 17)(q23;q25) and MLL-SEPT9 rearrangement in an elderly patient: a case study and review of the literature. Acta Haematol 2011; 126: 195-198.
18. Kim MJ, Cho SY, Kim MH, Lee JJ, Kang SY, Cho EH, Huh J, Yoon HJ, Park TS, Lee WI, Marschalek R, Meyer C: FISH-negative cryptic PML-RARA rearrangement detected by long-distance polymerase chain reaction and sequencing analyses: a case study and review of the literature. Cancer Genet Cytogenet 2010; 203: 278-283.
19. Lim G, Cho EH, Cho SY, Shin SY, Park JC, Yang YJ, Oh SH, Marschalek R, Meyer C, Park TS: A novel PML-ADAMTS17-RARA gene rearrangement in a patient with pregnancy-related acute promyelocytic leukemia. Leuk Res 2011; 35:e106-e110.
20. Lee SG, Park TS, Won SC, Song J, Lee KA, Choi JR, Marschalek R, Meyer C: Three-way translocation involving MLL, MLLT1, and a novel third partner, NRXN1, in a patient with acute lymphoblastic leukemia and t(2; 19; 11) (p12;p13.3;q23). Cancer Genet Cytogenet 2010; 197: 32-38.
21. Park TS, Lee SG, Song J, Lee KA, Kim J, Choi JR, Lee ST, Marschalek R, Meyer C: CASP8AP2 is a novel partner gene of MLL rearrangement with t(6; 11)(q15;q23) in acute myeloid leukemia. Cancer Genet Cytogenet 2009; 195: 94-95.
22. Meyer C, Brieger A, Plotz G, Weber N, Passmann S, Dingermann T, Zeuzem S, Trojan J, Marschalek R: An interstitial deletion at 3p21.3 results in the genetic fusion of MLH1 and ITGA9 in a Lynch syndrome family. Clin Cancer Res 2009; 15: 762-769.
23. Cin H, Meyer C, Herr R, Janzarik WG, Lambert S, Jones DT, Jacob K, Benner A, Witt H, Remke M, Bender S, Falkenstein F, Van Anh TN, Olbrich H, von Deimling A, Pekrun A, Kulozik AE, Gnekow A, Scheurlen W, Witt O, Omran H, Jabado N, Collins VP, Brummer T, Marschalek R, Lichter P, Korshunov A, Pfister SM: Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma. Acta Neuropathol 2011; 121: 763-774.